LCAM
LLY icon

London & Capital Asset Management’s Eli Lilly LLY Stock Holding History

London & Capital Asset Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$362K Sell
393
-1,480
-79% -$1.5M ﹤0.01% 180
2025
Q4 		$2.01M Buy
+1,873
New +$1.79M 0.02% 89

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

London & Capital Asset Management's LLY Position: Q1 2026 in Review

London & Capital Asset Management reduced its Eli Lilly (LLY) stake by 79% in Q1 2026, selling an estimated $1.5M and leaving 393 shares worth $362K. The position accounts for ﹤0.01% of the portfolio, ranked #180.

London & Capital Asset Management first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. The position peaked at $2.01M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • London & Capital Asset Management held 393 shares of Eli Lilly worth $362K as of Q1 2026.
  • London & Capital Asset Management sold 1,480 Eli Lilly shares in Q1 2026, an estimated $1.5M.
  • Eli Lilly made up ﹤0.01% of London & Capital Asset Management's portfolio in Q1 2026, its #180 holding.
  • London & Capital Asset Management first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
  • London & Capital Asset Management's Eli Lilly position peaked at $2.01M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on London & Capital Asset Management's 13F filing for Q1 2026, filed 15 May 2026.